Cystic Fibrosis
References
(1) Boucher RC. Cystic Fibrosis. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL et al., editors. Harrison's Internal Medicine. 16th ed. New York: McGraw-Hill; 2005. p. 1-9.
(2) Aitken M, Fiel SB, Stern RC. Cystic Fibrosis: Respiratory Manifestations. In: Taussig LM, Landau LI, editors. Pediatric Respiratory Medicine. 1st ed. St. Louis: Mosby, Inc.; 1999. p. 1-47.
(3) Welsh M. Cystic Fibrosis. In: Goldman L, Ausiello D, eds. Cecil Textbook of Medicine. 22nd ed. Philadelphia: WB Saunders; 2004. p. 1-22.
(4) National Heart Lung and Blood Institute. What Is Cystic Fibrosis. US Department of Health and Human Services National institute of Health 2005;1. Available at: URL: www.nhlbi.nih.gov/health
(5) Mason P. Cystic fibrosis-the disease. Hospital Pharmacist 2005;12:201-7.
(6) Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium. N Engl J Med 1993 October 28;329(18):1308-13.
(7) Knowles MR, Durie PR. What is cystic fibrosis? N Engl J Med 2002 August 8;347(6):439-42.
(8) Cystic Fibrosis Foundation. Patient Registry 2004 Annual Report. B; 2005.
(9) Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. PEDIATRICS 2001;107:1-13.
(10) National Digestive Diseases Information clearinghouse (NDDIC). Gallstones. What are Gallstones? Assessed February 2009
(11) Cystic Fibrosis Foundation – www.cff.org. Accessed August 2008
(12) Farrell, P. The prevalence of cystic fibrosis in the European Union, Case Report, March 2008
(13) Lieu TA, Ray GT, Farmer G, Shay GF. The cost of medical care for patients with cystic fibrosis in a health maintenance organization. Pediatrics 1999 June;103(6):e72.
(14) Moss RB. Administration of aerosolized antibiotics in cystic fibrosis patients. Chest 2001 September;120(3 Suppl):107S-13S.
(15) Ratjen F., Doring G., Nikolaizik W.H. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis, (2001) Lancet, 358 (9286), pp. 983-984
(16) HealthLine. Cystic Fibrosis image. Assessed February 2009.
(17) Britto MT, Kotagal UR, Hornung RW, Atherton HD, Tsevat J, Wilmott RW. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002 January;121(1):64-72.
(18) Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest 2004 January;125(1 Suppl):1S-39S.
(19) Beers MH, Fletcher AJ, Jones TV, Porter RS, Berkwits M, Kaplan JL. Cystic Fibrosis. The Merck Manual of Medical Information 2007;(2nd):1-8. Available at: URL: www.merckmedicus.com
(20) Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M. Cystic Fibrosis. The Merck Manual 2005;1-10. Available at: URL: www.merck.com
(21) Physiotherapy in the Treatment of Cystic Fibrosis. The Netherlands: Cystic Fibrosis Worldwide; 2002.
(22) Goss CH, Rubenfeld GD, Otto K, Aitken ML. The effect of pregnancy on survival in women with cystic fibrosis. Chest 2003 October;124(4):1460-8.
(23) Neglia JP, FitzSimmons SC, Maisonneuve P et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995 February 23;332(8):494-9.
(24) Comeau AM, Accurso FJ, White TB, et al. Guidelines for implementation of cystic fibrosis newborn screening programs: cystic fibrosis foundation workshop report. Pediatrics 2007;119:495-518.
(25) Cystic Fibrosis Foundation. Newborn Screening. CFF and CDC recommendations 2007. Accessed March 3, 2007.
(26) LeGrys VA. Assessment of sweat-testing practices for the diagnosis of cystic fibrosis. Arch Pathol Lab Med 2001 November;125:1420-4.
(27) Centers for Disease Control and Prevention. Newborn Screening for Cystic Fibrosis. Atlanta, GA: U.S Department of Health and Human Services; 2004 Oct 15. Report No.: MMWR/53/RR-13.
(28) Smyth RL. Diagnosis and management of cystic fibrosis. Arch Dis Child Ed Pract 2005;90:1-6.
(29) McCool FD, Rosen MJ. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest 2006;129:250-9.
(30) Cystic Fibrosis Foundation. Allergic Bronchopulmonary Aspergillosis. University of Wisconsin Hospital and Clinics 2005 July;1-2. Accessed February 28, 2007.
(31) Loening-Baucke V, Kimura K. Failure to pass meconium: diagnosing neonatal intestinal obstruction. Am Fam Physician. 1999:60;7;1-11.
(32) Agrons GA, Corse WR, Markowitz RI, Suarez ES, Perry DR. Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation. RadioGraphics 1996;16(4):871-93.
(33) Lai HC, Kosorok MR, Laxova A, Davis LA, FitzSimmon SC, Farrell PM. Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics 2000 January;105(1):53-61.
(34) Wilschanski M, Famini H, Strauss-Liviatan H, et al. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001;17:1208-15.
(35) Lynch A, Diamond D, Leader M. Point-of-need diagnosis of cystic fibrosis using a potentiometric ion-selective electrode array. Analyst 2000;125:2264-7.
(36) Domingo-Ribas C, Bosque-Garcia M. Nasal potential difference test to diagnose cystic fibrosis. Arch Bronconeumol 2006;42(1):33-8.
(37) tortora GJ, Derrickson B. The Respiratory System. In: tortora GJ, Derrickson B, editors. Principles of Anatomy and Physiolgy. 11th ed. Hoboken: John Wiley & Sons, Inc.; 2006. p. 846-94.
(38) Marieb EN. The Respiratory System. In: Marieb EN, editor. Human Anatomy and Physiology. 5th ed. San Francisco: Benjamin Cummings; 1999. p. 834-80.
(39) Irish MS. Surgical Aspects of Cystic Fibrosis and Meconium Ileus. eMedicine com 2006 July 31;1-25. Accessed March 6, 2007.
(40) Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microb Reviews 2002;15(2):194-222.
(41) Moorcroft AJ, Dodd ME, WebbAK. Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997;52:291-3.
(42) Doring G, Conway SP, Heijerman HGM, et al. Antibiotic therapy against pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-67.
(43) Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiology Reviews 2004 January;17(1):57-71.
(44) Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005;25(2):324-8.
(45) Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Eng J Med 2006 January 19;354:241-50.
(46) Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss B. High-dose oral N-acetylcysteine, a glutathione prodrug modulates inflammation in cystic fibrosis. PNAS 2006 March 21;103(12):4628-33.
(47) Braunwald Atlas of Internal Medicine